Tag Archives: Pharma

Purple Pill Update

Posted on November 13, 2015 by Mathew Lombard

Further to our post here, Judge Sue Robinson of the US District Court for the District of Delaware issued a temporary order banning Dr. Reddy’s from selling its generic version of AstraZeneca’s Nexium, after the pharmaceutical company objected to its … Continue reading →

Posted in Uncategorized | Tagged , , , | 1 Comment

AstraZeneca Asserts Its Purple Rights

Posted on November 6, 2015 by Mathew Lombard

**Update here** Global pharma giant AstraZeneca has asserted its rights to its purple trademark. AstraZeneca filed a complaint at the US District Court for the District of Delaware on 28 October, claiming Indian drug maker Dr. Reddy’s Laboratories’s generic version of Nexium … Continue reading →

Posted in Uncategorized | Tagged , , , | 1 Comment